HIV testing of at risk patients in a large integrated health care system
- PMID: 17356961
- PMCID: PMC1824727
- DOI: 10.1007/s11606-006-0028-9
HIV testing of at risk patients in a large integrated health care system
Abstract
Objective: Early identification of HIV infection is critical for patients to receive life-prolonging treatment and risk-reduction counseling. Understanding HIV screening practices and barriers to HIV testing is an important prelude to designing successful HIV screening programs. Our objective was to evaluate current practice patterns for identification of HIV.
Methods: We used a retrospective cohort analysis of 13,991 at-risk patients seen at 4 large Department of Veterans Affairs (VA) health-care systems. We also reviewed 1,100 medical records of tested patients. We assessed HIV testing rates among at-risk patients, the rationale for HIV testing, and predictors of HIV testing and of HIV infection.
Results: Of the 13,991 patients at risk for HIV, only 36% had been HIV-tested. The prevalence of HIV ranged from 1% to 20% among tested patients at the 4 sites. Approximately 90% of patients who were tested had a documented reason for testing.
Conclusion: One-half to two-thirds of patients at risk for HIV had not been tested within our selected VA sites. Among tested patients, the rationale for HIV testing was well documented. Further testing of at-risk patients could clearly benefit patients who have unidentified HIV infection by providing earlier access to life-prolonging therapy.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12693883', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12693883/'}]}
- Palella FJ, Jr., Deloria-Knoll M, Chmiel JS, et al. Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med. 2003;138(8):620–6. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJM199803263381301', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejm199803263381301'}, {'type': 'PubMed', 'value': '9516219', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9516219/'}]}
- Palella FJ, Jr., Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N Engl J Med. 1998;338(13):853–60. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMsa042657', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmsa042657'}, {'type': 'PubMed', 'value': '15703422', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15703422/'}]}
- Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570–85. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/01.aids.0000196166.48518.a0', 'is_inner': False, 'url': 'https://doi.org/10.1097/01.aids.0000196166.48518.a0'}, {'type': 'PubMed', 'value': '16511407', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/16511407/'}]}
- Crepaz N, Lyles CM, Wolitski RJ, et al. Do prevention interventions reduce HIV risk behaviors among people living with HIV? A meta-analytic review of controlled trials. AIDS. 2006;20(2):143–57. - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1001/jama.280.13.1161', 'is_inner': False, 'url': 'https://doi.org/10.1001/jama.280.13.1161'}, {'type': 'PubMed', 'value': '9777816', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9777816/'}]}
- Kamb ML, Fishbein M, Douglas JM, Jr., et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA. 1998;280(13):1161–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
